These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34791399)

  • 1. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
    Sattler MM; Crews JD
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy.
    Shirley DA; Tornel W; Warren CA; Moonah S
    Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37560802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Epidemiology of Clostridioides difficile Infections in Children.
    Perumalsamy S; Riley TV
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S34-S40. PubMed ID: 34791401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
    Dalal RS; Allegretti JR
    Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
    Reasoner SA; Nicholson MR
    Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the treatment of
    Gan Y; Wu ZH; Li QL; Lu ZX; Chen LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Sept 15; 26(9):995-1001. PubMed ID: 39267518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.
    Bednarska A; Sosińska-Bryła I; Hackiewicz M; Bursa D; Makowiecki M; Porowski D; Horban A
    Przegl Epidemiol; 2022; 77(1):23-33. PubMed ID: 37283245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to: Clostridioides difficile infection in children.
    Krutova M; de Meij TGJ; Fitzpatrick F; Drew RJ; Wilcox MH; Kuijper EJ
    Clin Microbiol Infect; 2022 Aug; 28(8):1085-1090. PubMed ID: 35283312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.
    Silva A; Du T; Choi KB; Pelude L; Golding GR; Hizon R; Lee BE; Chow B; Srigley JA; Hota SS; Comeau JL; Thampi N;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):222-225. PubMed ID: 36718660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
    Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.